TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Market Capitalization (2024 - 2025)

TFA Therapeutics (RAJAF) posted Market Capitalization of $1.0 billion for Q4 2025, up 11.27% on a QoQ basis from $916.7 million in Q4 2024, and up 11.27% year-over-year from $916.7 million in Q4 2024.

Analysis

TFA Therapeutics (RAJAF) Market Capitalization (2024 - 2025) Analysis & Trends

TFA Therapeutics has reported Market Capitalization for 2 years, with the latest figure at $1.0 billion in Q4 2025.

  • On a quarterly basis, Market Capitalization rose 11.27% year-over-year to $1.0 billion in Q4 2025; TTM through Dec 2025 was $1.0 billion, a 11.27% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 11.27% from the prior year.
  • Market Capitalization was $1.0 billion for Q4 2025 at TFA Therapeutics, up from $916.7 million in the prior quarter.
  • The five-year high for Market Capitalization was $1.0 billion in Q4 2025, with the low at $916.7 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Colgate Palmolive 70.53 Bn 69.16 Bn 3.30 Bn
2 Kenvue 34.61 Bn 33.50 Bn 2.30 Bn
3 Kimberly Clark 33.35 Bn 32.40 Bn 1.60 Bn
4 Bath & Body Works 4.00 Bn 3.20 Bn 692.00 Mn
5 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn -
6 Perrigo 2.01 Bn 1.61 Bn 313.90 Mn
7 Herbalife 1.27 Bn 903.35 Mn 1.03 Bn
8 Edgewell Personal Care 1.27 Bn 869.73 Mn 242.50 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn -
10 Honest Company 622.88 Mn 516.98 Mn 40.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.02 Bn
Dec 31, 2024 916.74 Mn